HEART UK launches ‘Prevention Pays’ analysis

HEART UK is proud to be publishing our new ‘Prevention Pays’ analysis. This analysis brings together publicly available data on the number of avoidable CVD events – such as heart attacks and strokes – and the estimated cost of them to the NHS, to estimate the potential saving to the NHS of reducing them. It also estimates the additional economic gains that could be made by people living longer healthier lives.

This analysis highlights that prevention pays. Investing in measures to prevent avoidable CVD events could help unlock precious NHS resource and provide much needed economic gains. Our findings suggest that savings from increased prevention could theoretically be as high as £2 billion.

The analysis can be read here,  Supporting information on methodology can be provided subject to request.

We are excited to be building on this work this year, and plan to use this new analysis to develop a prevention policy paper, due for publication later in the year.

Read our ‘Prevention Pays’ analysis

Disclaimer: Amarin, Amgen, Daiichi Sankyo and Novartis have contributed to the funding and production of this document, which has been written by HEART UK with input from the funding parties. Final editorial control lies with HEART UK.